← Every applicant
Avyxa Holdings FDA Approvals
10 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| NAVITRUXNew drugJun 24, 2026POWDER, INTRAVENOUS |
| FAVLYXANew drugFeb 20, 2026SOLUTION, INTRAVENOUS |
| AVOPEFNew drugFeb 13, 2026SOLUTION, INTRAVENOUS |
| VYKOURANew drugFeb 3, 2026SOLUTION, INTRAMUSCULAR, INTRAVENOUS |
| KYXATANew drugAug 8, 2025SOLUTION, INTRAVENOUS |
| BENDAMUSTINE HYDROCHLORIDENew drugJul 3, 2025SOLUTION, INTRAVENOUS |
| AVGEMSINew drugJun 27, 2025SOLUTION, INTRAVENOUS |
| AXTLENew drugJun 28, 2024POWDER, INTRAVENOUS |
| FRINDOVYXNew drugJun 7, 2023SOLUTION, INTRAVENOUS |
| DOCETAXELNew drugNov 22, 2022INJECTABLE, INJECTION |